Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |